GlycanAge
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$52.9M
Momentum Score
75 /100
Company Overview
GlycanAge is a biotech company that provides a biological age test designed to discover, measure, and optimize longevity by analyzing glycan biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycanAge Comps
Public and private peers based on sector, stage, and business model.
GlycanAge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Seed | Feb 19, 2024 |
Key People
Founding team and executive leadership
GlycanAge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LaunchHub Ventures | Series A |
| Lightfield Equity | Series A |
| South Central Ventures | Series A |
| BrightCap Ventures | Series A |
| Vesna Deep Tech Fund | Series A |
| Guinness Ventures | Series A |
| Kadmos Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$9M round closed
GlycanAge Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlycanAge's valuation, stock price, and market status.
